Director, Product Quality Leader

About Bio Marin

Bio Marin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health. Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities. Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need.

We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.

Bio Marin’s Technical Operations group is responsible for creating our drugs for use in clinical trials and for scaling production of those drugs for the commercial market. These engineers, technicians, scientists and support staff build and maintain Bio Marin’s cutting-edge manufacturing processes and sites, provide quality assurance and quality control to ensure we meet regulatory standards, and procure the needed goods and services to support manufacturing and coordinating the worldwide movement of our drugs to patients.

This individual will serve as a technical quality expert for one or more products during clinical development all the way through post-commercialization. The role is responsible for making technical quality-related decisions and serving as the single point of contact on the CMC (Chemistry, Manufacturing and Controls) team for all quality functions, risks and issues associated with the assigned products. As a core member of the CMC team, the PQL provides efficient and effective quality leadership of CMC-related strategic activities and drives associated quality decisions.

• As the single point of contact within a CMC Team for all product quality topics, participate fully in CMC team meetings and other relevant technical forums, providing technical quality expertise to influence global strategies and ensure robust implementation plans for product/program changes for all stages of the product life cycle (Pre-IND through post-Launch lifecycle management).
• Partner with CMC Team and the Quality organization to identify, develop and prioritize long-term product strategies/initiatives enabling the clinical to commercial transition, new product introductions and tech transfers; accountable for creation of the product-specific Quality strategy.
• Lead the cross-functional Quality Partner Team (QPT) supporting Quality-related CMC deliverables; accountable for managing the QPT deliverables in alignment with CMC execution plans, including timelines and scope. Responsible for timely and clear communication of all relevant information to and from the QPT to the CMC Team and functional managers.
• Own and manage the product quality risk register to ensure identification, resolution, mitigation and/or escalation of product quality issues and risks to CMC team and/or Senior Management.
• Responsible for developing a phase appropriate product specification as part of product control strategy creation; collaborate with CMC Lead to establish a phase appropriate Quality Target Product Profile (QTPP) and ensure the right quality characteristics are implemented during product development.
• Responsible for developing product comparability protocols and assessments for clinical-stage and commercial products, including sample selection and acceptance criteria identification needed to support process/site changes.
• Interpret and apply applicable regulatory guidelines and directives (e.g., 21
  
  CFR, USP, EP. JP, and ICH) to product quality, staying abreast of changes and advising stakeholders appropriately.
• Review and author regulatory…